Sumitomo Mitsui Trust Holdings, Inc. Dexcom Inc Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

$145 Billion
Q4 2024

A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 945,885 shares of DXCM stock, worth $81.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

945,885

Previous 949,565 0.39%

Holding current value

$81.8 Million

Previous $63.6 Million 15.59%

% of portfolio

0.05%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	SELL	$65.68 - $81.01 $241,702 - $298,116	-3,680 Reduced 0.39%	945,885 $73.6 Million
Q3 2024 Nov 05, 2024	BUY	$64.0 - $116.06 $3.55 Million - $6.45 Million	55,542 Added 6.21%	949,565 $63.6 Million
Q2 2024 Jul 19, 2024	SELL	$110.31 - $140.45 $10.9 Million - $13.9 Million	-98,981 Reduced 9.97%	894,023 $101 Million
Q1 2024 Apr 19, 2024	SELL	$114.22 - $140.1 $1.94 Million - $2.38 Million	-17,005 Reduced 1.68%	993,004 $138 Million
Q4 2023 Jan 30, 2024	SELL	$75.49 - $124.16 $1.33 Million - $2.19 Million	-17,661 Reduced 1.72%	1,010,009 $125 Million
Q3 2023 Oct 30, 2023	SELL	$86.06 - $137.93 $1.05 Million - $1.68 Million	-12,198 Reduced 1.17%	1,027,670 $95.9 Million
Q2 2023 Jul 31, 2023	SELL	$112.47 - $130.98 $7.48 Million - $8.71 Million	-66,465 Reduced 6.01%	1,039,868 $134 Million
Q1 2023 Apr 27, 2023	SELL	$104.0 - $122.92 $2.77 Million - $3.27 Million	-26,594 Reduced 2.35%	1,106,333 $129 Million
Q4 2022 Jan 30, 2023	SELL	$84.98 - $122.67 $122,711 - $177,135	-1,444 Reduced 0.13%	1,132,927 $128 Million
Q3 2022 Oct 21, 2022	BUY	$76.35 - $94.18 $266,614 - $328,876	3,492 Added 0.31%	1,134,371 $91.4 Million
Q2 2022 Jul 26, 2022	BUY	$67.99 - $132.89 $55.8 Million - $109 Million	820,093 Added 263.88%	1,130,879 $84.3 Million
Q1 2022 Apr 27, 2022	SELL	$94.08 - $130.2 $1.34 Million - $1.85 Million	-14,240 Reduced 4.38%	310,786 $159 Million
Q4 2021 Feb 02, 2022	SELL	$129.87 - $162.82 $14 Million - $17.5 Million	-107,515 Reduced 24.86%	325,026 $175 Million
Q3 2021 Oct 25, 2021	SELL	$106.71 - $143.18 $1.6 Million - $2.15 Million	-15,022 Reduced 3.36%	432,541 $237 Million
Q2 2021 Aug 02, 2021	SELL	$80.99 - $107.93 $1.21 Million - $1.62 Million	-14,991 Reduced 3.24%	447,563 $191 Million
Q1 2021 Apr 30, 2021	BUY	$84.79 - $104.74 $1.87 Million - $2.31 Million	22,058 Added 5.01%	462,554 $166 Million
Q4 2020 Feb 05, 2021	SELL	$78.0 - $104.5 $2.99 Million - $4.01 Million	-38,357 Reduced 8.01%	440,496 $163 Million
Q3 2020 Oct 30, 2020	BUY	$95.51 - $112.95 $3.12 Million - $3.69 Million	32,698 Added 7.33%	478,853 $197 Million
Q2 2020 Jul 27, 2020	SELL	$62.68 - $105.34 $6.99 Million - $11.7 Million	-111,492 Reduced 19.99%	446,155 $181 Million
Q1 2020 Apr 27, 2020	BUY	$47.79 - $75.63 $8.31 Million - $13.1 Million	173,794 Added 45.28%	557,647 $150 Million
Q4 2019 Jan 31, 2020	BUY	$36.62 - $57.29 $1.36 Million - $2.13 Million	37,096 Added 10.7%	383,853 $84 Million
Q3 2019 Oct 31, 2019	SELL	$35.53 - $43.8 $257,024 - $316,849	-7,234 Reduced 2.04%	346,757 $51.8 Million
Q2 2019 Jul 29, 2019	SELL	$27.84 - $38.92 $1.38 Million - $1.93 Million	-49,467 Reduced 12.26%	353,991 $53 Million
Q1 2019 May 08, 2019	BUY	$28.07 - $38.18 $547,168 - $744,242	19,493 Added 5.08%	403,458 $48.1 Million
Q4 2018 Feb 06, 2019	BUY	$26.99 - $37.37 $10.4 Million - $14.3 Million	383,965 New	383,965 $45.4 Million
Q4 2017 Feb 06, 2018	SELL	$11.12 - $15.38 $2.63 Million - $3.64 Million	-236,760 Closed	0 $0
Q3 2017 Nov 07, 2017	SELL	$11.36 - $18.98 $54,914 - $91,749	-4,834 Reduced 2.0%	236,760 $11.6 Million
Q2 2017 Aug 07, 2017	BUY	N/A	241,594	241,594 $17.7 Million

Others Institutions Holding DXCM

# of Institutions

1,022

Shares Held

352M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Account

Sumitomo Mitsui Trust Holdings, Inc. Dexcom Inc Transaction History